Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Jan;92(1):110-2.
doi: 10.1136/hrt.2004.056523. Epub 2005 Mar 29.

Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial

Randomized Controlled Trial

Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial

D Hürlimann et al. Heart. 2006 Jan.
No abstract available

PubMed Disclaimer

References

    1. Periard D, Telenti A, Sudre P.et al Atherogenic dyslipidemia in HIV‐infected individuals treated with protease inhibitors. The Swiss HIV cohort study. Circulation 1999100700–705. - PubMed
    1. Friis‐Moller N, Sabin C A, Weber R.et al Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 20033491993–2003. - PubMed
    1. Schachinger V, Britten M B, Zeiher A M. Prognostic impact of coronary vasodilator dysfunction on adverse long‐ term outcome of coronary heart disease. Circulation 20001011899–1906. - PubMed
    1. Stein J H, Klein M A, Bellehumeur J L.et al Use of human immunodeficiency virus‐1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001104257–262. - PubMed
    1. Fichtenbaum C J, Gerber J G, Rosenkranz S L.et al Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. Aids (London, England) 200216569–577. - PubMed

Publication types